Clinical Trial Update: Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing adjuvant mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer (AFFORD) awaiting recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MFOLFOX6
• MFOLFOXIRI

Snippet

Sponsor: Yanhong Deng | Conditions: Colorectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING